Literature DB >> 10208429

The translation initiation factor, hu-Sui1 may be a target of hepatitis B X antigen in hepatocarcinogenesis.

Z Lian1, J Pan, J Liu, S Zhang, M Zhu, P Arbuthnot, M Kew, M A Feitelson.   

Abstract

The role of hepatitis B virus X antigen in the development of hepatocellular carcinoma was explored by stably transfecting HepG2 cells with an X antigen expression vector, and identifying the differences in gene expression that distinguish X positive from X negative cells by subtractive PCR. One differentially expressed gene, the human homolog of sui1 (hu-sui1), encodes a translation initiation factor whose expression was suppressed by X antigen in HepG2 cells. Hu-Sui1 was also expressed in nontumor liver but not in tumor cells from patients with hepatocellular carcinoma. Introduction of hu-sui1 into HepG2 cells inhibited cell growth in culture, in soft agar, and partially inhibited tumor formation in nude mice. Hence, the suppression of hu-sui1 by X antigen may result in the abrogation of negative growth regulation and contribute to the development of hepatocellular carcinoma.

Entities:  

Mesh:

Substances:

Year:  1999        PMID: 10208429     DOI: 10.1038/sj.onc.1202470

Source DB:  PubMed          Journal:  Oncogene        ISSN: 0950-9232            Impact factor:   9.867


  18 in total

1.  Hepatitis Bx antigen stimulates expression of a novel cellular gene, URG4, that promotes hepatocellular growth and survival.

Authors:  N Lale Satiroglu Tufan; Zhaorui Lian; Jie Liu; Jingbo Pan; Patrick Arbuthnot; Michael Kew; Marcy M Clayton; Minghua Zhu; Mark A Feitelson
Journal:  Neoplasia       Date:  2002 Jul-Aug       Impact factor: 5.715

2.  Investigation of microRNA expression changes in HepG2 cell line in presence of URG4/URGCP and in absence of URG4/URGCP suppressed by RNA interference.

Authors:  Yavuz Dodurga; G Nilufer Yonguc; Cigir Biray Avci; Gulseren Bagci; Cumhur Gunduz; N Lale Satiroglu-Tufan
Journal:  Mol Biol Rep       Date:  2012-10-10       Impact factor: 2.316

Review 3.  Autoantibodies to tumor-associated antigens as diagnostic biomarkers in hepatocellular carcinoma and other solid tumors.

Authors:  Jian-Ying Zhang; Eng M Tan
Journal:  Expert Rev Mol Diagn       Date:  2010-04       Impact factor: 5.225

Review 4.  Hepatitis B virus and hepatocellular carcinoma.

Authors:  P Arbuthnot; M Kew
Journal:  Int J Exp Pathol       Date:  2001-04       Impact factor: 1.925

5.  Does the hepatitis B antigen HBx promote the appearance of liver cancer stem cells?

Authors:  Alla Arzumanyan; Tiffany Friedman; Irene O L Ng; Marcia M Clayton; Zhaorui Lian; Mark A Feitelson
Journal:  Cancer Res       Date:  2011-04-04       Impact factor: 12.701

6.  Autoantibody response to Sui1 and its tissue-specific expression in hepatocellular carcinoma.

Authors:  Jian-Wei Zhou; Yuan Li; Li-Xia Yue; Cheng-Lin Luo; Yao Chen; Jian-Ying Zhang
Journal:  Tumour Biol       Date:  2015-09-19

7.  Upregulated expression of a unique gene by hepatitis B x antigen promotes hepatocellular growth and tumorigenesis.

Authors:  Zhaorui Lian; Jie Liu; Li Li; Xianxing Li; N Lale Satiroglu Tufan; Marcy Clayton; Meng-Chao Wu; Hong-Yang Wang; Patrick Arbuthnot; Michael Kew; Mark A Feitelson
Journal:  Neoplasia       Date:  2003 May-Jun       Impact factor: 5.715

8.  Increased expression of ErbB-2 in liver is associated with hepatitis B x antigen and shorter survival in patients with liver cancer.

Authors:  Jie Liu; Angela Ahiekpor; Li Li; Xianxing Li; Patrick Arbuthnot; Michael Kew; Mark A Feitelson
Journal:  Int J Cancer       Date:  2009-10-15       Impact factor: 7.396

9.  Hedgehog signaling blockade delays hepatocarcinogenesis induced by hepatitis B virus X protein.

Authors:  Alla Arzumanyan; Vaishnavi Sambandam; Marcia M Clayton; Steve S Choi; Guanhua Xie; Anna Mae Diehl; Dae-Yeul Yu; Mark A Feitelson
Journal:  Cancer Res       Date:  2012-09-17       Impact factor: 12.701

10.  Autoantibodies to tumor-associated antigens combined with abnormal alpha-fetoprotein enhance immunodiagnosis of hepatocellular carcinoma.

Authors:  Yao Chen; Yusen Zhou; Suimin Qiu; Kaijuan Wang; Siwei Liu; Xuan-Xian Peng; Junfeng Li; Eng M Tan; Jian-Ying Zhang
Journal:  Cancer Lett       Date:  2009-08-15       Impact factor: 8.679

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.